Wade M. Aubry, M.D. is a medical technology consultant, health policy researcher, and clinician based in San Francisco. He is Senior Advisor for the Health Technology Center (HealthTech), where his work involves forecasting the impact of emerging technologies on the health care system. He is responsible for HealthTech’s methodology committee, health plan initiatives program, and federal liaison work, as well as for overseeing the production and updating of technology forecast reports. He is also Associate Director of the Center for Medical Technology Policy. Dr. Aubry has extensive experience with the Blue Cross Blue Shield system and Medicare, especially in technology assessment, coverage decisions, CPT coding, and quality initiatives. He is currently an advisor to the Blue Shield of California Foundation’s California Technology Assessment Forum and to the Blue Cross Blue Shield Association on CPT coding issues. He is Associate Clinical Professor of Medicine at the UCSF Institute for Health Policy Studies and a practicing endocrinologist at Saint Francis Hospital in San Francisco, where he chairs the hospital’s Institutional Review Board. Previously, he was Vice President of the Lewin Group, a health care consulting firm, Senior Vice President and Chief Medical Officer for Blue Shield of California, Medicare Part B Medical Director for Northern California, and National Medical Consultant for the BCBSA, where he chaired its Technology Evaluation Center’s national Medical Advisory Panel for 6 years.

Dr. Aubry received his B.S. degree Phi Beta Kappa from Stanford University, his M.D. degree from the UCLA School of Medicine, and his postgraduate training at Cedars-Sinai Medical Center in Los Angeles. He has served as a member of the AMA’s committee overseeing the revision of the CPT procedure coding system, NIH committees related to clinical trials and managed care, the IOM Committee on Technologies for the Early Detection of Breast Cancer (reported 2001), and the IOM Committee on Establishing a National Cord Blood Stem Cell Program (reported 2005). Currently, he is a member of the CMS Medicare Coverage Advisory Committee, the American College of Radiology Imaging Network (ACRIN) Advisory Panel, and the National Committee for Quality Assurance (NCQA) Geriatrics Measurement Advisory Panel, where he recently helped develop a new national performance measure for physical activity in Medicare health plans. His research interests are in medical technology assessment and coverage decision making. Currently, he is a member of the UCSF Effectiveness Center for the California Health Benefits Review Program (CHBRP), which produces evidence reports on proposed health insurance mandates in California. He has lectured internationally and published numerous articles on medical technology and managed care topics. He is co-author of a comprehensive case study on bone marrow transplants for breast cancer which will be published in 2006 by Oxford University Press entitled False Hope vs. Evidence-Based Medicine: Bone Marrow Transplantation for Breast Cancer.

Wade Aubry

Associate Director

Center for Medical Technology Policy

wade.aubry@cmtpnet.org